Medicine guide
Zerbaxa 1.5 g
As listed in the register: Zerbaxa 1.5 g, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1.5 g ·
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Ceftolozanum + Tazobactamum
- Made by
- MSD Merck Sharp & Dohme AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Infektionskrankheiten
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | MSD Merck Sharp & Dohme AG |
|---|---|
| Active substance | Ceftolozanum + Tazobactamum |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 1.5 g |
| Classification | J01DI54 · Antibiotics, antivirals and antifungals taken into the body |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Zerbaxa 1.5 g, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Packs | 10 Durchstechflasche(n) |
| Zulassungsnummer | 65472 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.